Skip to main content

Barcelona, April 14th, 2022 –  The company received the Ministry of Business and Labour of Catalonia, the Honorable Roger Torrent i Ramió and the Mayor of Malgrat de Mar, Sònia Viñolas. Also, authorities of Catalan Government agency Catalonia Trade & Investment and media.

The purpose of the visit was to announce an investment of 100 million US dollars and the creation of 100 new jobs by first half of 2024Thanks to this expansion, AGC Pharma Chemicals will increase a 30% the API production capacity.

The Catalonia Government authorities and company’s executives had a meeting, and they did a tour of the manufacturing plant. The Ministry of Business and Labour of Catalonia said to journalist during the visit that “AGC is betting on Malgrat de Mar, Maresme, and the company is a benchmark in the sector. With this kind of project Catalonia is positioning in a global pharmaceutical market”. Also, Torrent assured that it is a “strategic and key” sector and that “it will be even more in the future”.

The CEO of AGC Pharma Chemicals Europe, Akihiro Kadokura said that “we are very happy to announce a great expansion of the production plant with an investment of 90 million euros and the creation of 100 jobs in the first half of 2024”. Kadokura told the media that it will be “a more modern and technological plant” and that “Catalonia is a center of chemical and pharmaceutical industry with outstanding professionals”.

The authorities and AGC Pharma Chemicals executives visited the green field of the new expansion, the new R&D building and micronization plant.

Latest News

Events & ConventionsAGC Pharma Chemicals to Attend CPHI Japan 2026
8th April 2026

AGC Pharma Chemicals to Attend CPHI Japan 2026

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
Events & ConventionsAGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026
31st March 2026

AGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026

Best in Class distinctions for Overall Staff, Cultural Fit, Technology Use, and Scaling Support. Recognition within the Small/Mid-Size Small Molecule API group. Barcelona, March 30, 2026 – AGC Pharma Chemicals has…
How Reactors Work in a CDMO for Small Molecule APIsAll of ArticlesCDMO ProcessesCDMO TechnologyHow Reactors Work in a CDMO for Small Molecule APIs
13th March 2026

How Reactors Work in a CDMO for Small Molecule APIs

In a pharmaceutical Contract Development and Manufacturing Organization (CDMO), reactors are the foundational equipment where chemical reactions convert raw materials into intermediates and Active Pharmaceutical Ingredients (APIs) under tightly controlled…